| Timetable |
| Download Conference Program |
| Download All Abstracts |
| Zoom Access |
| Corporate Program |
Late Breaking Posters
Day 1, June 22（Sun.）
Room P (Maesato East, Foyer, Ocean Wing)
- 1P-LB-09
Developing Multiple Biomarkers of Human Lung Cancer Using Multiomics.
(NTOU)
oFang-Hsuan Chang
Multidisciplinary approaches integrating proteomics, metabolomics, and lipidomics are advancing the study of lung cancer biomarkers to enhance early diagnosis and treatment outcomes. Proteomic analyses of serum from lung cancer patients have identified disease-associated protein alterations, offering insights into potential new biomarkers. Metabolomics reveals significant metabolic disruptions in these patients, highlighting candidate diagnostic markers. Lipidomic studies demonstrate abnormal lipid metabolism in lung cancer cells, pinpointing specific lipid markers that may aid in early detection. By combining these multi-omics datasets, we aim to deepen the understanding of lung cancer's molecular mechanisms and support the development of personalized medicine.